ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $61,000 | +103.3% | 15,910 | 0.0% | 0.01% | +75.0% |
| Q4 2018 | $30,000 | -41.2% | 15,910 | 0.0% | 0.00% | -42.9% |
| Q3 2018 | $51,000 | +6.2% | 15,910 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $48,000 | -28.4% | 15,910 | -7.0% | 0.01% | -36.4% |
| Q1 2018 | $67,000 | -5.6% | 17,110 | 0.0% | 0.01% | -8.3% |
| Q4 2017 | $71,000 | -32.4% | 17,110 | 0.0% | 0.01% | -36.8% |
| Q3 2017 | $105,000 | -0.9% | 17,110 | 0.0% | 0.02% | -5.0% |
| Q2 2017 | $106,000 | -1.9% | 17,110 | 0.0% | 0.02% | -4.8% |
| Q1 2017 | $108,000 | +14.9% | 17,110 | 0.0% | 0.02% | -16.0% |
| Q2 2016 | $94,000 | -26.0% | 17,110 | 0.0% | 0.02% | -26.5% |
| Q1 2016 | $127,000 | -23.5% | 17,110 | -14.3% | 0.03% | -27.7% |
| Q4 2015 | $166,000 | -7.8% | 19,960 | 0.0% | 0.05% | -13.0% |
| Q3 2015 | $180,000 | +15.4% | 19,960 | +37.7% | 0.05% | +1.9% |
| Q2 2015 | $156,000 | – | 14,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |